GeoVax Labs, Inc. (NASDAQ:GOVXW) Short Interest Up 500.0% in August

GeoVax Labs, Inc. (NASDAQ:GOVXW) was the target of a large increase in short interest in August. As of August 15th, there was short interest totalling 1,800 shares, an increase of 500.0% from the July 31st total of 300 shares. Based on an average daily trading volume, of 38,700 shares, the short-interest ratio is currently 0.0 days.

GeoVax Labs Stock Performance

GOVXW opened at $0.44 on Thursday. GeoVax Labs has a 12 month low of $0.02 and a 12 month high of $0.65. The company has a fifty day simple moving average of $0.18 and a 200 day simple moving average of $0.09.

GeoVax Labs Company Profile

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers.